Streetbeat News

Stock Prices

AZZ

AZZ shares are trading lower following a downgrade by Noble Capital Markets from Outperform to Market Perform.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:20 pm

ALAB

Astera Labs shares are experiencing an increase in their trading value due to post-IPO volatility.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:17 pm

KIM

Kimco Realty's stock trades lower following a downgrade by Citigroup from Buy to Neutral, with a reduced price target from $26 to $20.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:16 pm

HYZN

Hyzon Motors is set to feature in a live segment on Fox Business titled 'Hyzon's Hydrogen Powered Big Rig', which has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:14 pm

GOOG

GOOGL

RDDT

Reddit Inc (NYSE:RDDT) saw its shares surge in their debut, amidst discussions on monetizing its user base by licensing data to AI firms, including a $60 million deal with Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL). This move, aimed at revenue growth, raises concerns about user privacy and the impact on user engagement. Analysts predict significant revenue growth for Reddit, while the FTC shows interest in the Google deal. Reddit's IPO was successful, with shares closing up 48% on the first day.

Portfolio Pulse from Chris Katje

March 22, 2024 | 7:12 pm

BITF

COIN

MARA

MSTR

RIOT

Crypto-related stocks such as BITF, COIN, MARA, MSTR, and RIOT are trading lower due to a decline in Bitcoin's value.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:11 pm

ACN

Accenture Plc (NYSE:ACN) reported mixed Q2 fiscal 2024 results with sales of $15.80 billion, slightly missing consensus but within guidance. Adjusted EPS of $2.77 beat consensus. The company adjusted its fiscal 2024 revenue growth forecast to 1%-3% and EPS to $11.97-$12.20, below consensus. Shares fell 2.2% following the announcement. Analysts from Mizuho, RBC Capital, TD Cowen, Morgan Stanley, BMO Capital, and Citigroup revised their price targets on Accenture.

Portfolio Pulse from Avi Kapoor

March 22, 2024 | 7:07 pm

IVVD

Invivyd, Inc. (NASDAQ:IVVD) announced FDA emergency use authorization (EUA) for PEMGARDA (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents with moderate-to-severe immune compromise. This marks the first EUA for a monoclonal antibody (mAb) based on Invivyd's novel technology platform, aimed at addressing rapid viral evolution. The authorization is supported by positive data from the CANOPY clinical trial and ongoing in vitro activity against major SARS-CoV-2 variants. Product availability in the U.S. is expected imminently. Invivyd also reported having $200.6 million in cash and cash equivalents as of December 31, 2023, and raised an additional $40.5 million in February 2024 to strengthen its balance sheet ahead of the PEMGARDA launch.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:07 pm

PARA

PARAA

Paramount Global's stock (PARA, PARAA) declined following reports that Shari Redstone favors a deal with Skydance over Apollo's bid for Paramount Studio.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:05 pm

NVDA

NVIDIA's stock price increased following UBS's decision to maintain a Buy rating and raise its price target from $800 to $1,100.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:04 pm